Business Description
Quest Diagnostics Inc
NAICS : 621511
SIC : 8071
ISIN : US74834L1008
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.09 | |||||
Equity-to-Asset | 0.46 | |||||
Debt-to-Equity | 0.83 | |||||
Debt-to-EBITDA | 3.07 | |||||
Interest Coverage | 7.18 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 3.1 | |||||
Beneish M-Score | -2.58 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.7 | |||||
3-Year EBITDA Growth Rate | -4.7 | |||||
3-Year EPS without NRI Growth Rate | -6 | |||||
3-Year FCF Growth Rate | -13.1 | |||||
3-Year Book Growth Rate | 3.7 | |||||
Future 3-5Y EPS without NRI Growth Rate | 4.97 | |||||
Future 3-5Y Total Revenue Growth Rate | 2.5 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.97 | |||||
Quick Ratio | 0.89 | |||||
Cash Ratio | 0.21 | |||||
Days Inventory | 10.88 | |||||
Days Sales Outstanding | 49.54 | |||||
Days Payable | 20.55 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 7.6 | |||||
3-Year Average Share Buyback Ratio | 5.7 | |||||
Shareholder Yield % | -1.41 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 32.87 | |||||
Operating Margin % | 13.54 | |||||
Net Margin % | 9.11 | |||||
FCF Margin % | 10.24 | |||||
ROE % | 13.44 | |||||
ROA % | 6.25 | |||||
ROIC % | 8.01 | |||||
ROC (Joel Greenblatt) % | 44.97 | |||||
ROCE % | 11.02 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 18.45 | |||||
Forward PE Ratio | 15.57 | |||||
PE Ratio without NRI | 16.86 | |||||
Shiller PE Ratio | 15.98 | |||||
Price-to-Owner-Earnings | 20.14 | |||||
PEG Ratio | 1.72 | |||||
PS Ratio | 1.67 | |||||
PB Ratio | 2.37 | |||||
Price-to-Free-Cash-Flow | 16.35 | |||||
Price-to-Operating-Cash-Flow | 11.63 | |||||
EV-to-EBIT | 15.54 | |||||
EV-to-Forward-EBIT | 13.47 | |||||
EV-to-EBITDA | 11.54 | |||||
EV-to-Forward-EBITDA | 11.08 | |||||
EV-to-Revenue | 2.17 | |||||
EV-to-Forward-Revenue | 2.16 | |||||
EV-to-FCF | 21.23 | |||||
Price-to-Projected-FCF | 0.75 | |||||
Price-to-Median-PS-Value | 0.98 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.89 | |||||
Earnings Yield (Greenblatt) % | 6.44 | |||||
FCF Yield % | 6.22 | |||||
Forward Rate of Return (Yacktman) % | 16.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Quest Diagnostics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil MXN) | 159,040.695 | ||
EPS (TTM) (MXN) | 127.335 | ||
Beta | 0.25 | ||
Volatility % | 0.86 | ||
14-Day RSI | 0 | ||
14-Day ATR (MXN) | 0 | ||
20-Day SMA (MXN) | 2458.05 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (MXN) | 2458.05 - 2458.05 | ||
Shares Outstanding (Mil) | 111.09 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Quest Diagnostics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Quest Diagnostics Inc Stock Events
Event | Date | Price(MXN) | ||
---|---|---|---|---|
No Event Data |
Quest Diagnostics Inc Frequently Asked Questions
What is Quest Diagnostics Inc(MEX:DGX)'s stock price today?
When is next earnings date of Quest Diagnostics Inc(MEX:DGX)?
Does Quest Diagnostics Inc(MEX:DGX) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |